ÂÜÀòÂÒÂ×

Claudia Wolf-Werner joined vasopharm in September 2002 and acted as a technical assistant in preclinical R&D until October 2008. From November 2008 to June 2013 she assumed the role of a Clinical Research Associate (CRA) on the VAS203 program, mainly in the field of Co-Monitoring in line with the European multicentre Phase IIa study (NOSTRA trial). She was subsequently appointed CRA & Project Manager for the Phase Ic study in July 2013. In March 2014 Claudia took over the responsibility for Co-Monitoring, and as main contact point of vasopharm for the study sites, the entire management of the sites of the European Phase III (NOSTRA-III) multicentre trial in her current role as Clinical Trial Manager. In May 2020 she further assumed the role as Quality Manager.

She started her professional training in October 1998 at the Professional School for Laboratory Technical Assistants, University of Erlangen, Germany, and spent afterwards one year at the University Clinic of Wuerzburg, Germany (Department of Internal Medicine / Nephrology) before joining vasopharm.